aphiahsone 50 mikrogram/dos nässpray, suspension
glenmark arzneimittel gmbh - mometasonfuroatmonohydrat - nässpray, suspension - 50 mikrogram/dos - mometasonfuroatmonohydrat 51,73 mikrog aktiv substans; etanol, vattenfri hjälpämne; bensalkoniumklorid hjälpämne; glycerol hjälpämne - mometason
nasonex 50 mikrogram/dos nässpray, suspension
orifarm ab - mometasonfuroatmonohydrat - nässpray, suspension - 50 mikrogram/dos - glycerol hjälpämne; bensalkoniumklorid hjälpämne; mometasonfuroatmonohydrat 52 mikrog aktiv substans
orimox 50 mikrogram/dos nässpray, suspension
orifarm generics a/s - mometasonfuroatmonohydrat - nässpray, suspension - 50 mikrogram/dos - glycerol hjälpämne; mometasonfuroatmonohydrat 52 mikrog aktiv substans; bensalkoniumklorid hjälpämne
momenex 50 mikrogram/dos nässpray, suspension
2care4 generics aps - mometasonfuroatmonohydrat - nässpray, suspension - 50 mikrogram/dos - mometasonfuroatmonohydrat 52 mikrog aktiv substans; bensalkoniumklorid hjälpämne; glycerol 85% hjälpämne
nasonex 50 mikrogram/dos nässpray, suspension
ebb medical ab - mometasonfuroatmonohydrat - nässpray, suspension - 50 mikrogram/dos - glycerol hjälpämne; mometasonfuroatmonohydrat 52 mikrog aktiv substans; bensalkoniumklorid hjälpämne
mometason ebb 50 mikrogram/dos nässpray, suspension
ebb medical ab - mometasonfuroatmonohydrat - nässpray, suspension - 50 mikrogram/dos - mometasonfuroatmonohydrat 52 mikrog aktiv substans; bensalkoniumklorid hjälpämne; glycerol hjälpämne
enerzair breezhaler
novartis europharm limited - indacaterol, glycopyrronium bromide, mometasone - astma - läkemedel mot obstruktiv lungsjukdom, - enerzair breezhaler is indicated as a maintenance treatment of asthma in adult patients not adequately controlled with a maintenance combination of a long acting beta2 agonist and a high dose of an inhaled corticosteroid who experienced one or more asthma exacerbations in the previous year.
bemrist breezhaler
novartis europharm limited - indacaterol, mometasone furoate - astma - läkemedel mot obstruktiv lungsjukdom, - bemrist breezhaler is indicated as a maintenance treatment of asthma in adults and adolescents 12 years of age and older not adequately controlled with inhaled corticosteroids and inhaled short acting beta2-agonists.
atectura breezhaler
novartis europharm limited - indacaterol acetate, mometasone furoate - astma - läkemedel mot obstruktiv lungsjukdom, - atectura breezhaler is indicated as a maintenance treatment of asthma in adults and adolescents 12 years of age and older not adequately controlled with inhaled corticosteroids and inhaled short acting beta2-agonists.
zimbus breezhaler
novartis europharm limited - glycopyrronium bromide, indacaterol (acetate), mometasone furoate - astma - läkemedel mot obstruktiv lungsjukdom, - maintenance treatment of asthma in adults whose disease is not adequately controlled.